UK markets close in 2 hours 52 minutes

AIM ImmunoTech Inc. (0A4Y.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.3987-0.0214 (-5.09%)
As of 04:20PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.11
52-week change 3-18.62%
S&P500 52-week change 327.84%
52-week high 30.7200
52-week low 30.0000
50-day moving average 30.4790
200-day moving average 30.5130

Share statistics

Avg vol (3-month) 34.76k
Avg vol (10-day) 38.43k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 845.33M
% held by insiders 19.00%
% held by institutions 18.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.022727:1
Last split date 311 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-21,544.62%

Management effectiveness

Return on assets (ttm)-66.64%
Return on equity (ttm)-118.94%

Income statement

Revenue (ttm)202k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)16.10%
Gross profit (ttm)N/A
EBITDA -31.68M
Net income avi to common (ttm)-28.96M
Diluted EPS (ttm)-0.4040
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.07M
Total cash per share (mrq)0.26
Total debt (mrq)718k
Total debt/equity (mrq)7.02%
Current ratio (mrq)1.68
Book value per share (mrq)0.19

Cash flow statement

Operating cash flow (ttm)-21.27M
Levered free cash flow (ttm)-12.16M